Description
The primary mechanism of SS-31 is its interaction with cardiolipin, a unique phospholipid found exclusively in the inner mitochondrial membrane. Cardiolipin is critical for:
- Mitochondrial respiration and ATP production
- Maintaining the shape and integrity of mitochondria
- Anchoring respiratory complexes of the electron transport chain
As we age or experience oxidative stress, cardiolipin becomes damaged or oxidized, leading to:
- Mitochondrial membrane leakage
- Reduced ATP production
- Increased ROS (reactive oxygen species)
- Cell death or dysfunction
SS-31 works by:
- Binding to cardiolipin to preserve mitochondrial structure
- Preventing peroxidation of cardiolipin
- Enhancing efficiency of the electron transport chain
- Improving ATP synthesis
- Reducing production of ROS
Conditions That May Benefit from SS-31
While more human data is needed, SS-31 has shown potential in:
- Chronic fatigue syndrome / ME/CFS
- Fibromyalgia
- Post-viral syndromes
- Mitochondrial myopathies
- Parkinson’s and Alzheimer’s disease
- Heart failure or cardiomyopathy
- Type 2 diabetes and metabolic syndrome
- Aging-related frailty
- Long COVID (hypothesized mechanism)
Disclaimer: This information is for educational purposes based on research studies and does not constitute medical advice. Consult a healthcare provider before starting any peptide therapy.
Reviews
There are no reviews yet.